1,701 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Purchased by Virtu Financial LLC

Virtu Financial LLC acquired a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, according to the company in its most recent filing with the SEC. The firm acquired 1,701 shares of the biotechnology company’s stock, valued at approximately $439,000.

Other hedge funds have also recently modified their holdings of the company. Sands Capital Management LLC boosted its position in Axon Enterprise by 0.6% in the fourth quarter. Sands Capital Management LLC now owns 2,628,652 shares of the biotechnology company’s stock worth $679,060,000 after purchasing an additional 16,347 shares during the last quarter. Wellington Management Group LLP grew its position in Axon Enterprise by 3.3% during the third quarter. Wellington Management Group LLP now owns 1,956,022 shares of the biotechnology company’s stock valued at $389,229,000 after buying an additional 62,324 shares during the period. Norges Bank purchased a new stake in Axon Enterprise during the fourth quarter worth about $195,406,000. Westfield Capital Management Co. LP boosted its stake in Axon Enterprise by 5.1% in the fourth quarter. Westfield Capital Management Co. LP now owns 731,721 shares of the biotechnology company’s stock valued at $189,025,000 after acquiring an additional 35,528 shares during the last quarter. Finally, Northern Trust Corp grew its position in shares of Axon Enterprise by 3.1% during the 3rd quarter. Northern Trust Corp now owns 631,212 shares of the biotechnology company’s stock valued at $125,605,000 after acquiring an additional 19,068 shares during the period. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Down 1.2 %

AXON opened at $293.52 on Wednesday. The firm has a market capitalization of $22.15 billion, a P/E ratio of 85.82 and a beta of 0.91. Axon Enterprise, Inc. has a one year low of $175.37 and a one year high of $329.87. The company has a fifty day moving average price of $297.23 and a 200-day moving average price of $282.10. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.91 and a quick ratio of 2.55.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Friday, May 10th. The biotechnology company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $0.95 by $0.20. Axon Enterprise had a return on equity of 11.71% and a net margin of 15.60%. The firm had revenue of $460.74 million for the quarter, compared to analysts’ expectations of $441.57 million. During the same quarter last year, the firm posted $0.51 EPS. The company’s revenue was up 34.3% compared to the same quarter last year. Equities research analysts expect that Axon Enterprise, Inc. will post 2.35 earnings per share for the current fiscal year.

Insider Buying and Selling at Axon Enterprise

In other news, President Joshua Isner sold 44,000 shares of Axon Enterprise stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $309.96, for a total transaction of $13,638,240.00. Following the completion of the sale, the president now directly owns 275,843 shares of the company’s stock, valued at approximately $85,500,296.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Axon Enterprise news, insider Jeffrey C. Kunins sold 43,668 shares of the business’s stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $309.94, for a total value of $13,534,459.92. Following the completion of the sale, the insider now directly owns 189,719 shares of the company’s stock, valued at $58,801,506.86. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, President Joshua Isner sold 44,000 shares of the firm’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $309.96, for a total value of $13,638,240.00. Following the transaction, the president now directly owns 275,843 shares in the company, valued at $85,500,296.28. The disclosure for this sale can be found here. Insiders sold a total of 89,447 shares of company stock worth $27,684,677 over the last three months. 5.70% of the stock is owned by insiders.

Analyst Ratings Changes

Several research firms recently commented on AXON. Barclays upped their price objective on Axon Enterprise from $308.00 to $381.00 and gave the company an “overweight” rating in a research note on Wednesday, May 8th. JMP Securities reissued a “market outperform” rating and issued a $375.00 price objective on shares of Axon Enterprise in a report on Tuesday, May 7th. William Blair reaffirmed an “outperform” rating on shares of Axon Enterprise in a report on Wednesday, April 24th. Morgan Stanley lifted their target price on shares of Axon Enterprise from $285.00 to $310.00 and gave the stock an “equal weight” rating in a research note on Friday, April 26th. Finally, Craig Hallum upped their price target on shares of Axon Enterprise from $325.00 to $370.00 and gave the company a “buy” rating in a research note on Tuesday, May 7th. Two analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and a consensus target price of $335.27.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.